Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication

Psychosomatic Medicine

Volumn 72, Issue 9, 2010, Pages 925-932

  Benton, Tami ^a,c   Lynch, Kevin ^a   Dubé, Benoit ^a   Gettes, David R ^a   Tustin, Nancy B ^a,d   Lai, Jian Ping ^a,d   Metzger, David S ^a   Blume, Joshua ^a   Douglas, Steven D ^a,d   Evans, Dwight L ^a,b  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Division of Immunology   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Depression; Human immunodeficiency virus acquired immune deficiency syndrome; Immunity; Serotonin

Indexed keywords

CITALOPRAM; RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MACROPHAGE; MAJOR DEPRESSION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; CITALOPRAM; DEPRESSIVE DISORDER; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HIV; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; VIRAL LOAD; VIRUS REPLICATION;

EID: 78651360666     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181f883ce     Document Type: Article

References (74)

1. Mossner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 1998;12:249-71.
2. Young MR, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 1995;84:148-52.
3. Hellstrand K, Hermodsson S. Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16-NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunol 1990;127:199-214.
4. Mizruchin A, Gold I, Krasnov I, Livshitz G, Shahin R, Kook AI. Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system. J Neuroimmunol 1999; 101:201-4.
5. Dustin ML, Colman DR. Neural and immunological synaptic relations. Science 2002;298:785-9.
6. Jackson JC, Walker RF, Brooks WH, Roszman TL. Specific uptake of serotonin by murine macrophages. Life Sci 1988;42:1641-50.
7. Finocchiaro LM, Arzt ES, Fernandez-Castelo S, Criscuolo M, Finkielman S, Nahmod VE. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. J Interferon Res 1988;8:705-16. (Pubitemid 19042691)
8. Faraj BA, Olkowski ZL, Jackson RT. Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immunopharmacol 1994;16:561-7.
9. Aune TM, Kelley KA, Ranges GE, Bombara MP. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol 1990;145:1826-31.
10. Choquet D, Korn H. Dual effects of serotonin on a voltage-gated conductance in lymphocytes. Proc Natl Acad Sci U S A 1988;85:4557-61.
11. Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 1988;335:358-60.
12. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 1994;51:865-74.
13. Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 2005;5:835-43.
14. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 1998;102:223-31.
15. Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 2002;9:1893-903.
16. Maneglier B, Guillemin GJ, Clayette P, Rogez-Kreuz C, Brew BJ, Dormont D, Dadvenier C, Therond P, Spreux-Varorquaux O. Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors. Br J Pharmacol 2008;154:174-82.
17. Ironson G, Hayward H. Do positive psychosocial factors predict disease progression in HIV? A review of the evidence. Psychosom Med 2008; 70:546-54.
18. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O'Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits P Jr, Valvo WJ. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005;58:175-89.
19. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993;270:2568-73.
20. Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE, Wang YL, Cruess D, Dube B, Dalen EA, Brown T, Bauer R, Petitto JM. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002;159:1752-9.
21. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J, Group HIVERS. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA 2001;285: 1466-74.
22. Patterson TL, Shaw WS, Semple SJ, Cherner M, McCutchan JA, Atkinson JH, Grant I, Nannis E. Relationships of psychosocial factors to HIV disease progression. Ann Behav Med 1996;18:30-9.
23. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, Treisman GJ. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 1996;153:1430-7.
24. Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med 1996;156:2233-8.
25. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W Jr. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol 1996;6:420-30.
26. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539-45.
27. Temoshok LR, Wald RL, Synowski S, Garzino-Demo A. Coping as a multisystem construct associated with pathways mediating HIV-relevant immune function and disease progression. Psychosom Med 2008;70: 555-61.
28. Irwin M, Daniels M, Bloom ET, Smith TL, Weiner H. Life events, depressive symptoms, and immune function. Am J Psychiatry 1987;144: 437-41.
29. Stein M, Miller AH, Trestman RL. Depression, the immune system, and health and illness. Findings in search of meaning. Arch Gen Psychiatry 1991;48:171-7.
30. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-86.
31. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993; 329:1246-53.
32. Evans DL, Folds JD, Petitto JM, Golden RN, Pedersen CA, Corrigan M, Gilmore JH, Silva SG, Quade D, Ozer H. Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. Arch Gen Psychiatry 1992;49: 388-95.
33. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry 1997;54:279-85.
34. Frank MG, Hendricks SE, Johnson DR, Wieseler JL, Burke WJ. Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 1999;39:18-24.
35. Kook AI, Mizruchin A, Odnopozov N, Gershon H, Segev Y. Depression and immunity: the biochemical interrelationship between the central nervous system and the immune system. Biol Psychiatry 1995;37:817-9.
36. Evans DL, Lynch KG, Benton T, Dube B, Gettes DR, Tustin NB, Lai JP, Metzger D, Douglas SD. Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol Psychiatry 2008;63:899-905.
37. Lai JP, Ho WZ, Zhan GX, Yi Y, Collman RG, Douglas SD. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci USA 2001;98:3970-5.
38. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992;8:191-7.
39. Cassol E, Alfano M, Biswas P, Poli G. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol 2006;80:1018-30.
40. Ho WZ, Tomassini N, Cherukuri R, Shun DG, Song L, Lee HR, Douglas SD. Monokine-mediated increase in human immunodeficiency virus type 1 expression in chronically infected promonocyte- and T-cell-derived lines. Clin Diagn Lab Immunol 1994;1:517-25.
41. Ho WZ, Lai JP, Li Y, Douglas SD. HIV enhances substance P expression in human immune cells. FASEB J 2002;16:616-8.
42. Perkins DO, Stern RA, Golden RN, Murphy C, Naftolowitz D, Evans DL. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry 1994;151:233-6.
43. Petitto JM, Folds JD, Ozer H, Quade D, Evans DL. Abnormal diurnal variation in circulating natural killer cell phenotypes and cytotoxic activity in major depression. Am J Psychiatry 1992;149:694-6.
44. Hassan NF, Campbell DE, Douglas SD. Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods 1986;95:273-6.
45. Chen BK, Saksela K, Andino R, Baltimore D. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferaseencoding viruses. J Virol 1994;68:654-60.
46. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988;62:139-47.
47. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokineinduced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238:800-2.
48. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 1989;86:2365-8.
49. Ho WZ, Cnaan A, Li YH, Zhao H, Lee HR, Song L, Douglas SD. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses 1996;12:195-8.
50. Cruess DG, Douglas SD, Petitto JM, Have TT, Gettes D, Dube B, Cary M, Evans DL. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry 2005;162:2125-30.
51. Evans DL, Charney DS. Mood disorders and medical illness: a major public health problem. Biol Psychiatry 2003;54:177-80.
52. Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M. Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 1989;46:81-7.
53. Evans DL, Leserman J, Pedersen CA, Golden RN, Lewis MH, Folds JA, Ozer H. Immune correlates of stress and depression. Psychopharmacol Bull 1989;25:319-24.
54. Phillips M, Evans D (editors). Methods in Neurosciences. San Diego: Academic Press, Harcourt Brace Jovanovich; 1995.
55. Rabin B. Stress, Immune Function, and Health: The Connection. New York: Wiley-Liss and Sons; 1999.
56. Sephton SE, Kraemer HC, Neri E, Stites DP, Weissbecker I, Spiegel D. Improving methods of assessing natural killer cell cytotoxicity. Int J Methods Psychiatr Res 2006;15:12-21.
57. Glaser R, Rabin B, Chesney M, Cohen S, Natelson B. Stress-induced immunomodulation: implications for infectious diseases? JAMA 1999; 281:2268-70.
58. Kiecolt-Glaser JD, Glaser, R. Depression and immune function central pathways to morbidity and mortality. J Psychosom Res 2002;53:873-6.
59. Raison CL, Miller AH. The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry 2001;6:277-94.
60. + T cells. Science 1995;270: 1811-5.
61. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992;175:789-96.
62. Bandyopadhyay S, Ziegner U, Campbell DE, Miller DS, Hoxie JA, Starr SE. Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1. Clin Exp Immunol 1990;79:430-5.
63. Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996;124:654-63.
64. + cell suppressor factors and cytotoxic T lymphocytes during HIV infection. AIDS Res Hum Retroviruses 1998;14(Suppl 2):S153-60.
65. + cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines. Pro Natl Acad Sci of the USA 1998;95: 1725-9.
66. Mann JJ. The medical management of depression. N Engl J Med 2005; 353:1819-34.
67. Hellstrand K, Hermodsson S. Role of serotonin in the regulation of human natural killer cell cytotoxicity. J Immunology 1987;139:869-75. (Pubitemid 17107090)
68. Aune TM, Golden HW, McGrath KM. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 1994;153: 489-98.
69. Irwin M, Lacher U, Caldwell C. Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol Med 1992;22:1045-50.
70. Hofmann B, Nishanian P, Nguyen T, Liu M, Fahey JL. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993;7:659-64.
71. Hofmann B, Afzelius P, Iversen J, Kronborg G, Aabech P, Benfield T, Dybkjaer E, Nielsen JO. Buspirone, a serotonin receptor agonist, increases CD4 T-cell counts and modulates the immune system in HIVseropositive subjects. AIDS 1996;10:1339-47.
72. Eugen-Olsen J, Afzelius P, Andresen L, Iversen J, Kronborg G, Aabech P, Nielsen JO, Hofmann B. Serotonin modulates immune function in T cells from HIV-seropositive subjects. Clin Immunol Immunopathol 1997; 84:115-21.
73. Gordon J, Barnes NM. Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol 2003;24:438-43.
74. O'Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 2006;107:1010-7.